JANUS HENDERSON GROUP PLC - 29 Nov 2024 SCHEDULE 13G/A Report for MEREO BIOPHARMA GROUP PLC American Depositary Shares (MREO)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
MEREO BIOPHARMA GROUP PLC American Depositary Shares
Symbol
MREO
Shares outstanding
154,536,495 shares
Disclosed Ownership
15,917,259 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
06 Dec 2024, 11:37:10 UTC
Date of event
29 Nov 2024
Next filing
14 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 10% 15,917,259 0 15,917,259 Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 9.3% 14,384,501 0 14,384,501 Kristin Mariani Head of North America Compliance, CCO